Back
Open Access

Long-term efficacy of mavacamten on cardiac structure and function in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy: long-term extension of EXPLORER-CN trial

Session: Hypertrophic cardiomyopathy
Topic: Hypertrophic Cardiomyopathy
Speaker: Doctor Z. Tian (Beijing, CN)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Zhuang Tian

Peking Union Medical College Hospital, Beijing (China)
1 presentation
1 follower

6 more presentations in this session

Characterisation of interrelations among myocardial work parameters in patients with hypertrophic cardiomyopathy: differences between non-obstructive and obstructive disease

Speaker: Doctor A. Kormanyos (Szeged, HU)

Access
Abstract
Like
Thumbnail

The role of stress echocardiography to unmask latent LVOT obstruction in hypertrophic cardiomyopathy

Speaker: Doctor D. Faro (Mascalucia, IT)

Access
Abstract
Like
Thumbnail

The influence of genotype on the phenotype and prognosis of patients with hypertrophic cardiomyopathy

Speaker: Miss I. Conde (Braga, PT)

Access
Abstract
Like
Thumbnail

Examining ECG's performance as a screening method for hypertrophic cardiomyopathy: phenotypic correlations and evaluation

Speaker: Doctor I. Martins Moreira (Vila Real, PT)

Access
Abstract
Like
Thumbnail

Decrease of ECG hypertrophy indices during mavacamten treatment in obstructive hypertrophic cardiomyopathy

Speaker: Doctor R. Sepp (Szeged, HU)

Access
Abstract
Like
Thumbnail

Access the full session

Hypertrophic cardiomyopathy

Speakers: Doctor Z. Tian, Doctor A. Kormanyos, Doctor D. Faro, Miss I. Conde, Doctor I. Martins Moreira...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources